Logo image of JEN.DE

JENOPTIK AG (JEN.DE) Stock Fundamental Analysis

FRA:JEN - Deutsche Boerse Ag - DE000A2NB601 - Common Stock - Currency: EUR

19.31  -0.03 (-0.16%)

Fundamental Rating

5

Overall JEN gets a fundamental rating of 5 out of 10. We evaluated JEN against 53 industry peers in the Electronic Equipment, Instruments & Components industry. JEN has an excellent profitability rating, but there are some minor concerns on its financial health. JEN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

JEN had positive earnings in the past year.
In the past year JEN had a positive cash flow from operations.
Each year in the past 5 years JEN has been profitable.
Each year in the past 5 years JEN had a positive operating cash flow.
JEN.DE Yearly Net Income VS EBIT VS OCF VS FCFJEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 5.14%, JEN is doing good in the industry, outperforming 79.25% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.97%, JEN is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
JEN has a better Return On Invested Capital (7.16%) than 73.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JEN is in line with the industry average of 7.71%.
The 3 year average ROIC (7.15%) for JEN is below the current ROIC(7.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.14%
ROE 8.97%
ROIC 7.16%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
JEN.DE Yearly ROA, ROE, ROICJEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

The Profit Margin of JEN (7.85%) is better than 83.02% of its industry peers.
In the last couple of years the Profit Margin of JEN has remained more or less at the same level.
Looking at the Operating Margin, with a value of 12.46%, JEN belongs to the top of the industry, outperforming 86.79% of the companies in the same industry.
JEN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 33.03%, JEN is not doing good in the industry: 66.04% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of JEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.46%
PM (TTM) 7.85%
GM 33.03%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
JEN.DE Yearly Profit, Operating, Gross MarginsJEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JEN is still creating some value.
The number of shares outstanding for JEN remains at a similar level compared to 1 year ago.
The number of shares outstanding for JEN remains at a similar level compared to 5 years ago.
JEN has a better debt/assets ratio than last year.
JEN.DE Yearly Shares OutstandingJEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JEN.DE Yearly Total Debt VS Total AssetsJEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.50 indicates that JEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.50, JEN perfoms like the industry average, outperforming 52.83% of the companies in the same industry.
The Debt to FCF ratio of JEN is 5.44, which is a neutral value as it means it would take JEN, 5.44 years of fcf income to pay off all of its debts.
JEN has a Debt to FCF ratio of 5.44. This is comparable to the rest of the industry: JEN outperforms 54.72% of its industry peers.
JEN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
JEN has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: JEN outperforms 56.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 5.44
Altman-Z 2.5
ROIC/WACC1.26
WACC5.68%
JEN.DE Yearly LT Debt VS Equity VS FCFJEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.52 indicates that JEN should not have too much problems paying its short term obligations.
The Current ratio of JEN (1.52) is comparable to the rest of the industry.
JEN has a Quick Ratio of 1.52. This is a bad value and indicates that JEN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, JEN is doing worse than 75.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.77
JEN.DE Yearly Current Assets VS Current LiabilitesJEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

JEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.53%, which is quite good.
The Earnings Per Share has been growing slightly by 6.54% on average over the past years.
The Revenue has been growing slightly by 1.39% in the past year.
JEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.46% yearly.
EPS 1Y (TTM)13.53%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-40.74%
Revenue 1Y (TTM)1.39%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-4.9%

3.2 Future

The Earnings Per Share is expected to grow by 10.19% on average over the next years. This is quite good.
JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y5.08%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
EPS Next 5Y10.19%
Revenue Next Year0.18%
Revenue Next 2Y2.88%
Revenue Next 3Y3.15%
Revenue Next 5Y3.76%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.DE Yearly Revenue VS EstimatesJEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
JEN.DE Yearly EPS VS EstimatesJEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.79, JEN is valued correctly.
81.13% of the companies in the same industry are more expensive than JEN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of JEN to the average of the S&P500 Index (27.91), we can say JEN is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.55, the valuation of JEN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, JEN is valued a bit cheaper than the industry average as 77.36% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of JEN to the average of the S&P500 Index (37.11), we can say JEN is valued rather cheaply.
Industry RankSector Rank
PE 12.79
Fwd PE 9.55
JEN.DE Price Earnings VS Forward Price EarningsJEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than the industry average as 64.15% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JEN indicates a somewhat cheap valuation: JEN is cheaper than 64.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.87
EV/EBITDA 6.91
JEN.DE Per share dataJEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JEN does not grow enough to justify the current Price/Earnings ratio.
JEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.52
PEG (5Y)1.95
EPS Next 2Y11.72%
EPS Next 3Y10.46%

4

5. Dividend

5.1 Amount

JEN has a Yearly Dividend Yield of 1.99%. Purely for dividend investing, there may be better candidates out there.
JEN's Dividend Yield is a higher than the industry average which is at 2.86.
Compared to an average S&P500 Dividend Yield of 2.32, JEN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.99%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years0
JEN.DE Yearly Dividends per shareJEN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

23.13% of the earnings are spent on dividend by JEN. This is a low number and sustainable payout ratio.
DP23.13%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
JEN.DE Yearly Income VS Free CF VS DividendJEN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
JEN.DE Dividend Payout.JEN.DE Dividend Payout, showing the Payout Ratio.JEN.DE Dividend Payout.PayoutRetained Earnings

JENOPTIK AG

FRA:JEN (7/29/2025, 5:29:47 PM)

19.31

-0.03 (-0.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners40.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.11B
Analysts82.35
Price Target26.02 (34.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.99%
Yearly Dividend0.35
Dividend Growth(5Y)0%
DP23.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.18%
Min EPS beat(2)-20.99%
Max EPS beat(2)4.63%
EPS beat(4)2
Avg EPS beat(4)-1.45%
Min EPS beat(4)-20.99%
Max EPS beat(4)13.86%
EPS beat(8)3
Avg EPS beat(8)-7.97%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)-1.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)2.62%
Revenue beat(8)2
Avg Revenue beat(8)-5.53%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.75%
PT rev (3m)-9.46%
EPS NQ rev (1m)-1.26%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.02%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 12.79
Fwd PE 9.55
P/S 1
P/FCF 13.87
P/OCF 6.14
P/B 1.15
P/tB 3.91
EV/EBITDA 6.91
EPS(TTM)1.51
EY7.82%
EPS(NY)2.02
Fwd EY10.47%
FCF(TTM)1.39
FCFY7.21%
OCF(TTM)3.14
OCFY16.28%
SpS19.27
BVpS16.86
TBVpS4.94
PEG (NY)2.52
PEG (5Y)1.95
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 8.97%
ROCE 10.43%
ROIC 7.16%
ROICexc 7.5%
ROICexgc 16.37%
OM 12.46%
PM (TTM) 7.85%
GM 33.03%
FCFM 7.22%
ROA(3y)4.32%
ROA(5y)4.15%
ROE(3y)8.12%
ROE(5y)8.24%
ROIC(3y)7.15%
ROIC(5y)6.58%
ROICexc(3y)7.54%
ROICexc(5y)6.96%
ROICexgc(3y)16.1%
ROICexgc(5y)15.71%
ROCE(3y)10.41%
ROCE(5y)9.58%
ROICexcg growth 3Y-2.02%
ROICexcg growth 5Y2.07%
ROICexc growth 3Y7.18%
ROICexc growth 5Y-3.9%
OM growth 3Y-1.94%
OM growth 5Y5.73%
PM growth 3Y-8.73%
PM growth 5Y0.97%
GM growth 3Y0.54%
GM growth 5Y0.38%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 5.44
Debt/EBITDA 1.42
Cap/Depr 132.32%
Cap/Sales 9.09%
Interest Coverage 8.57
Cash Conversion 84.38%
Profit Quality 91.98%
Current Ratio 1.52
Quick Ratio 0.77
Altman-Z 2.5
F-Score5
WACC5.68%
ROIC/WACC1.26
Cap/Depr(3y)121.37%
Cap/Depr(5y)106.88%
Cap/Sales(3y)8.22%
Cap/Sales(5y)7.57%
Profit Quality(3y)101.44%
Profit Quality(5y)95.78%
High Growth Momentum
Growth
EPS 1Y (TTM)13.53%
EPS 3Y4.03%
EPS 5Y6.54%
EPS Q2Q%-40.74%
EPS Next Y5.08%
EPS Next 2Y11.72%
EPS Next 3Y10.46%
EPS Next 5Y10.19%
Revenue 1Y (TTM)1.39%
Revenue growth 3Y14.12%
Revenue growth 5Y5.46%
Sales Q2Q%-4.9%
Revenue Next Year0.18%
Revenue Next 2Y2.88%
Revenue Next 3Y3.15%
Revenue Next 5Y3.76%
EBIT growth 1Y3.83%
EBIT growth 3Y11.91%
EBIT growth 5Y11.51%
EBIT Next Year46.8%
EBIT Next 3Y21.91%
EBIT Next 5Y14.54%
FCF growth 1Y-8.38%
FCF growth 3Y12.68%
FCF growth 5Y2.87%
OCF growth 1Y6.31%
OCF growth 3Y19.51%
OCF growth 5Y8.88%